current treatment approaches in et and an insight into the surpass-et trial
Published 1 year ago • 86 plays • Length 1:46Download video MP4
Download video MP3
Similar videos
-
2:38
advancing mcl treatment: combination therapies and updates from sympatico
-
1:02
emerging treatment options for lower- and higher-risk mds and ongoing trials
-
1:04
the current standard of care for mds-related cytopenias and how treatment strategies may evolve
-
4:32
recent advances in the treatment of lr-mds: commands and imerge trial data
-
2:44
latest updates in the treatment of lr-mds: commands and imerge trials
-
2:55
current and emerging treatments for mf: an update from ash 2023
-
2:00
the development of anti-fibrotic agents for treating myelofibrosis
-
3:02
novel treatments and ongoing clinical trials for wm: targeted agents and immunotherapies
-
1:33
the current guidelines and therapies for tp53-mutated mds and aml
-
2:16
current and future treatment approaches for hr-mds
-
2:49
results from the phase iii echo trial of acalabrutinib plus br in mcl
-
0:56
the current treatment landscape in cll
-
0:58
management strategies for acute and chronic gvhd following allosct
-
2:33
novel immunotherapies in aml and insights into the future of the treatment landscape
-
0:55
the role of clinical trials in improving treatment options for scd
-
0:58
current research and next steps to improve the understanding and management of icaht
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
2:35
methods of optimizing transplantation in mds